We are live on
!
Find out more
BCM
Brown Capital Management Portfolio holdings
AUM
$500M
1-Year Est. Return
25.3%
This Fund
S&P 500
This Quarter
Est. Return
+6.93%
1 Year Est. Return
+25.3%
3 Year Est. Return
+79.24%
5 Year Est. Return
+57.49%
10 Year Est. Return
+614.96%
AUM
$13.2B
AUM Growth
-$239M
(-1.8%)
Cap. Flow
-$1.01B
Cap. Flow
% of AUM
-7.63%
Top 10 Holdings %
Top 10 Hldgs %
45.05%
Holding
128
New
1
Increased
42
Reduced
52
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
10x Genomics
TXG
|
+$99.6M |
| 2 |
AppFolio
APPF
|
+$74.4M |
| 3 |
Repligen
RGEN
|
+$56.6M |
| 4 |
SMAR
Smartsheet Inc.
SMAR
|
+$53.3M |
| 5 |
QuidelOrtho
QDEL
|
+$44.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iRhythm Holdings
IRTC
|
+$376M |
| 2 |
Manhattan Associates
MANH
|
+$166M |
| 3 |
Bio-Techne
TECH
|
+$108M |
| 4 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
+$98.2M |
| 5 |
EGOV
NIC Inc
EGOV
|
+$88.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 57.13% |
| 2 | Healthcare | 37% |
| 3 | Industrials | 4.38% |
| 4 | Materials | 0.8% |
| 5 | Consumer Discretionary | 0.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Cognex
CGNX
$10.5B
| $697M | 5.28% |
8,289,995
-335,267
| -4% | -$27.1M |
|
2
Veeva Systems
VEEV
$44.5B
| $691M | 5.24% |
2,222,724
-116,258
| -5% | -$32.4M |
|
3
Tyler Technologies
TYL
$14.9B
| $669M | 5.07% |
1,479,660
-39,560
| -3% | -$16.8M |
|
|
4
Manhattan Associates
MANH
$12.5B
| $644M | 4.88% |
4,449,171
-1,248,316
| -22% | -$166M |
|
5
Paycom
PAYC
$10.4B
| $612M | 4.64% |
1,682,597
-69,808
| -4% | -$24.7M |
|
6
Neogen
NEOG
$2.58B
| $569M | 4.32% |
12,369,212
-603,380
| -5% | -$27.9M |
|
|
SMAR
7
DELISTED
Smartsheet Inc.
SMAR
| $540M | 4.1% |
7,471,620
+853,946
| +13% | +$53.3M |
|
8
Datadog
DDOG
$76.5B
| $509M | 3.86% |
4,893,004
+440,562
| +10% | +$39.8M |
|
9
Q2 Holdings
QTWO
$3.87B
| $509M | 3.86% |
4,961,488
+410,371
| +9% | +$41.1M |
|
10
Alarm.com
ALRM
$2.77B
| $502M | 3.81% |
5,931,648
+444,404
| +8% | +$38M |
|
11
Glaukos
GKOS
$10.5B
| $494M | 3.75% |
5,827,070
-527,779
| -8% | -$43.3M |
|
|
12
Bio-Techne
TECH
$11.4B
| $488M | 3.7% |
4,335,488
-1,029,100
| -19% | -$108M |
|
|
ABMD
13
DELISTED
Abiomed Inc
ABMD
| $481M | 3.65% |
1,541,472
-60,077
| -4% | -$18.4M |
|
|
14
AppFolio
APPF
$7.59B
| $479M | 3.63% |
3,395,644
+535,970
| +19% | +$74.4M |
|
|
ANSS
15
DELISTED
Ansys
ANSS
| $455M | 3.45% |
1,310,726
-80,677
| -6% | -$27.9M |
|
16
Guidewire Software
GWRE
$13.5B
| $341M | 2.58% |
3,023,446
-47,617
| -2% | -$4.95M |
|
|
17
QuidelOrtho
QDEL
$958M
| $339M | 2.57% |
2,644,609
+378,368
| +17% | +$44.5M |
|
|
PRO
18
DELISTED
PROS Holdings
PRO
| $292M | 2.21% |
6,397,237
-142,050
| -2% | -$6.28M |
|
|
CSII
19
DELISTED
Cardiovascular Systems, Inc.
CSII
| $256M | 1.94% |
6,007,119
+1,846
| +0% | +$72.2K |
|
|
PLAN
20
DELISTED
Anaplan, Inc.
PLAN
| $252M | 1.91% |
4,718,610
-184,533
| -4% | -$10.3M |
|
21
Vericel Corp
VCEL
$2.06B
| $241M | 1.83% |
4,589,819
+19,766
| +0.4% | +$1.13M |
|
|
22
10x Genomics
TXG
$8.16B
| $241M | 1.82% |
1,228,685
+550,344
| +81% | +$99.6M |
|
23
Inogen
INGN
$144M
| $240M | 1.82% |
3,685,147
-254,313
| -6% | -$16.1M |
|
24
Ironwood Pharmaceuticals
IRWD
$704M
| $238M | 1.8% |
18,484,759
-1,685,367
| -8% | -$19.3M |
|
25
Protolabs
PRLB
$1.95B
| $212M | 1.61% |
2,311,222
-745,671
| -24% | -$73.5M |
|
Similar funds
HC
TLP
ISWM
PT
FGWP
PCA
FNBOMD
TPWM
Brown Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, Brown Capital Management held 128 positions worth $13.2B, down 1.8% from $13.4B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Brown Capital Management withdrew a net $1.01B in Q2 2021, closing 6 positions and reducing 52 holdings. Its most notable exit was iRhythm Holdings, an estimated $376M position sold in full.
By sector, the portfolio is most concentrated in Technology at 57% of assets, up from 54% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Brown Capital Management opened a new position in Insulet worth $2.12M.
- Brown Capital Management's largest Q2 2021 buy was Insulet: 7,736 shares worth $2.12M.
- Brown Capital Management added most to 10x Genomics in Q2 2021, an estimated $99.6M increase.
- Brown Capital Management's biggest Q2 2021 reduction was Manhattan Associates, cutting an estimated $166M.
- Brown Capital Management fully exited iRhythm Holdings in Q2 2021, selling an estimated $376M.
- Brown Capital Management's ten largest holdings make up 45% of its $13.2B portfolio in Q2 2021.
- Brown Capital Management opened 1 new position and closed 6 in Q2 2021.
- Brown Capital Management's portfolio value fell 1.8% quarter-over-quarter to $13.2B.
Based on Brown Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.